1
|
Ahmad R, Rehman U, Sohaib Sarwar M, Ahmed Z, Adebayo O, Brennan PA. Use of autogenous fascia lata slings in the surgical correction of ptosis: a systematic review of the literature and meta-analysis. Br J Oral Maxillofac Surg 2024; 62:128-139. [PMID: 38290862 DOI: 10.1016/j.bjoms.2023.11.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Accepted: 11/28/2023] [Indexed: 02/01/2024]
Abstract
Ptosis is an abnormally low-positioned upper eyelid. Management depends on severity, aetiology, and function of the levator palpebrae superioris muscle (LPS). This review evaluates the success of autogenous fascia lata slings (AFLS) in the surgical management of ptosis, together with complication and reoperation/revision rates. A literature search was conducted on PubMed, Google Scholar PROSPERO, Dynamed, DARE, EMBASE, Cochrane, and BMJ databases (PROSPERO registration: CRD42023475090), and 30 studies (3690 patients and 5059 eyes) were included. The average age of the patients was 14.2 years with a ratio of male:female patients of 1:0.7. A total of 2532 eyes had undergone a fascial sling with autogenous fascia lata. The average follow-up period was 32.6 months. Improvement in the margin to reflex distance 1 (MRD1) with fascial sling surgery was 2.79 mm. The rate of complications from surgery involving autogenous fascia lata was 21.3%. The most common complications included lagophthalmos (19.8%), residual ptosis (11.5%), and corneal damage (10.4%). The reoperation rate was 13.4%. Most common indications for reoperation were cosmetic, with asymmetry (18%), lid crease abnormalities (30%), and upper eyelid trimming (18%). The overall complication rate in AFLS patients was 20% (95% CI: 6 to 35, p < 0.01; I2 = 89%) versus 27% (95% CI: 14 to 40, p < 0.01; I2 = 90%) in non-AFLS patients. AFLSs are prudent in the surgical management of ptosis. The results of this review demonstrate that their use is associated with similar complication rates but fewer reoperations than other traditional techniques.
Collapse
Affiliation(s)
- Reddin Ahmad
- Core Surgical Trainee 1, Plastic Department, University Hospitals Leicester NHS Trust, Leicester, United Kingdom.
| | - Umar Rehman
- Clinical Research Fellow, UCL Division of Surgery and Interventional Sciences, UCL, London, United Kingdom.
| | - Mohammad Sohaib Sarwar
- Locum Clinical Fellow, Department of Oral and Maxillofacial Surgery, The Queen Victoria Hospital, East Grinstead, United Kingdom.
| | - Zahra Ahmed
- Medical Student, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
| | - Oluwasemilore Adebayo
- Foundation Doctor, Department of Surgery, Lister Hospital, Stevanage, United Kingdom.
| | - Peter A Brennan
- Honorary Professor of Surgery, Consultant Oral and Maxillofacial Surgeon, Department of Oral and Maxillofacial Surgery, Queen Alexandra Hospital, Portsmouth, United Kingdom.
| |
Collapse
|
2
|
Park RB, Akella SS, Aakalu VK. A review of surgical management of progressive myogenic ptosis. Orbit 2023; 42:11-24. [PMID: 36178005 PMCID: PMC10329817 DOI: 10.1080/01676830.2022.2122514] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Accepted: 08/29/2022] [Indexed: 05/28/2023]
Abstract
PURPOSE Surgical correction of myogenic ptosis is a sophisticated endeavor, as the disease is progressive and the post-operative course is prone to significant complications. We sought to review the literature for repair techniques in different types of myogenic ptosis. METHODS A PubMed/MEDLINE literature search of publications pertaining to surgical outcomes of progressive myogenic ptosis repair was performed. Studies included were original retrospective studies with a minimum of four patients. RESULTS A total of 27 articles were identified and divided by etiology of myogenic ptosis; either chronic progressive external ophthalmoplegia (CPEO), oculopharyngeal muscular dystrophy (OPMD), myasthenia gravis (MG), or mixed. Surgical techniques predominantly involved levator advancement, levator resection, frontalis sling, blepharoplasty, and Fasanella-Servat. Success rates ranged from 60.5% to 100%. Significant postoperative complications included ptosis recurrence, under-correction, over-correction, keratopathy, lagophthalmos, sling exposure, and sling infection. CONCLUSION Like surgical repair for other forms of ptosis, correction of progressive myogenic ptosis is guided by levator excursion. However, myogenic ptosis is especially challenging as it is characterized by worsening ptosis and the loss of protective corneal mechanisms. The goals of care with myogenic ptosis involves repairing ptosis just sufficiently to alleviate visual obstruction while avoiding adverse post-operative complications. This intentional under-correction subsequently increases susceptibility for ptosis recurrence. Myogenic ptosis repair therefore requires delicate balancing between function, sustained repair, and corneal protection.
Collapse
Affiliation(s)
- Royce B. Park
- Department of Ophthalmology, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL
| | - Sruti S. Akella
- Department of Ophthalmology, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL
| | - Vinay K. Aakalu
- Department of Ophthalmology, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL
| |
Collapse
|
3
|
Lock JH, Irani NK, Newman NJ. Neuro-ophthalmic manifestations of mitochondrial disorders and their management. Taiwan J Ophthalmol 2020; 11:39-52. [PMID: 33767954 PMCID: PMC7971441 DOI: 10.4103/tjo.tjo_68_20] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2020] [Accepted: 09/23/2020] [Indexed: 12/30/2022] Open
Abstract
The visual system has high metabolic requirements and is therefore particularly vulnerable to mitochondrial dysfunction. The most commonly affected tissues include the extraocular muscles, photoreceptors, retinal pigment epithelium, optic nerve and visual cortex. Hence, the most common manifestations of mitochondrial disorders are progressive external ophthalmoplegia, macular pattern dystrophy, pigmentary retinopathy, optic neuropathy and retrochiasmal visual field loss. With the exception of Leber hereditary optic neuropathy and stroke-like episodes seen in mitochondrial encephalopathy, lactic acidosis and stroke-like episodes, the majority of neuro-ophthalmic manifestations have an insidious onset. As such, some patients may not recognize subtle progressive visual symptoms. When mitochondrial disorders are highly suspected, meticulous examination performed by an ophthalmologist with targeted ancillary testing can help confirm the diagnosis. Similarly, neuro-ophthalmic symptoms and signs may be the first indication of mitochondrial disease and should prompt systemic investigations for potentially life-threatening associations, such as cardiac conduction defects. Finally, the ophthalmologist can offer symptomatic treatments for some of the most disabling manifestations of these disorders.
Collapse
Affiliation(s)
- Jane H Lock
- Department of Ophthalmology, Royal Perth Hospital, Perth, WA, Australia.,Department of Ophthalmology, Sir Charles Gairdner Hospital, Perth, WA, Australia.,Department of Ophthalmology, Perth's Children's Hospital, Perth, WA, Australia
| | - Neha K Irani
- Department of Ophthalmology, Royal Perth Hospital, Perth, WA, Australia.,Department of Neurology, Fiona Stanley Hospital, Perth, WA, Australia.,Department of Neurology, Joondalup Health Campus, Perth, WA, Australia
| | - Nancy J Newman
- Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA, USA.,Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.,Department of Neurological Surgery, Emory University School of Medicine, Atlanta, GA, USA
| |
Collapse
|
4
|
Thatcher J, Chang YM, Chapman MN, Hovis K, Fujita A, Sobel R, Sakai O. Clinical-Radiologic Correlation of Extraocular Eye Movement Disorders: Seeing beneath the Surface. Radiographics 2016; 36:2123-2139. [PMID: 27831838 DOI: 10.1148/rg.2016150227] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Extraocular eye movement disorders are relatively common and may be a significant source of discomfort and morbidity for patients. The presence of restricted eye movement can be detected clinically with quick, easily performed, noninvasive maneuvers that assess medial, lateral, upward, and downward gaze. However, detecting the presence of ocular dysmotility may not be sufficient to pinpoint the exact cause of eye restriction. Imaging plays an important role in excluding, in some cases, and detecting, in others, a specific cause responsible for the clinical presentation. However, the radiologist should be aware that the imaging findings in many of these conditions when taken in isolation from the clinical history and symptoms are often nonspecific. Normal eye movements are directly controlled by the ocular motor cranial nerves (CN III, IV, and VI) in coordination with indirect input or sensory stimuli derived from other cranial nerves. Specific causes of ocular dysmotility can be localized to the cranial nerve nuclei in the brainstem, the cranial nerve pathways in the peripheral nervous system, and the extraocular muscles in the orbit, with disease at any of these sites manifesting clinically as an eye movement disorder. A thorough understanding of central nervous system anatomy, cranial nerve pathways, and orbital anatomy, as well as familiarity with patterns of eye movement restriction, are necessary for accurate detection of radiologic abnormalities that support a diagnostic source of the suspected extraocular movement disorder. ©RSNA, 2016.
Collapse
Affiliation(s)
- Joshua Thatcher
- From the Departments of Radiology (J.T., Y.M.C., M.N.C., K.H., A.F., O.S.), Ophthalmology (R.S.), Otolaryngology-Head and Neck Surgery (O.S.), and Radiation Oncology (O.S.), Boston Medical Center, Boston University School of Medicine, 820 Harrison Ave, 3rd Floor, Boston, MA 02118; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Mass (Y.M.C.); Department of Radiology, Veterans Administration Boston Healthcare System, Boston, Mass (M.N.C.); and Department of Radiology, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan (A.F.)
| | - Yu-Ming Chang
- From the Departments of Radiology (J.T., Y.M.C., M.N.C., K.H., A.F., O.S.), Ophthalmology (R.S.), Otolaryngology-Head and Neck Surgery (O.S.), and Radiation Oncology (O.S.), Boston Medical Center, Boston University School of Medicine, 820 Harrison Ave, 3rd Floor, Boston, MA 02118; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Mass (Y.M.C.); Department of Radiology, Veterans Administration Boston Healthcare System, Boston, Mass (M.N.C.); and Department of Radiology, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan (A.F.)
| | - Margaret N Chapman
- From the Departments of Radiology (J.T., Y.M.C., M.N.C., K.H., A.F., O.S.), Ophthalmology (R.S.), Otolaryngology-Head and Neck Surgery (O.S.), and Radiation Oncology (O.S.), Boston Medical Center, Boston University School of Medicine, 820 Harrison Ave, 3rd Floor, Boston, MA 02118; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Mass (Y.M.C.); Department of Radiology, Veterans Administration Boston Healthcare System, Boston, Mass (M.N.C.); and Department of Radiology, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan (A.F.)
| | - Keegan Hovis
- From the Departments of Radiology (J.T., Y.M.C., M.N.C., K.H., A.F., O.S.), Ophthalmology (R.S.), Otolaryngology-Head and Neck Surgery (O.S.), and Radiation Oncology (O.S.), Boston Medical Center, Boston University School of Medicine, 820 Harrison Ave, 3rd Floor, Boston, MA 02118; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Mass (Y.M.C.); Department of Radiology, Veterans Administration Boston Healthcare System, Boston, Mass (M.N.C.); and Department of Radiology, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan (A.F.)
| | - Akifumi Fujita
- From the Departments of Radiology (J.T., Y.M.C., M.N.C., K.H., A.F., O.S.), Ophthalmology (R.S.), Otolaryngology-Head and Neck Surgery (O.S.), and Radiation Oncology (O.S.), Boston Medical Center, Boston University School of Medicine, 820 Harrison Ave, 3rd Floor, Boston, MA 02118; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Mass (Y.M.C.); Department of Radiology, Veterans Administration Boston Healthcare System, Boston, Mass (M.N.C.); and Department of Radiology, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan (A.F.)
| | - Rachel Sobel
- From the Departments of Radiology (J.T., Y.M.C., M.N.C., K.H., A.F., O.S.), Ophthalmology (R.S.), Otolaryngology-Head and Neck Surgery (O.S.), and Radiation Oncology (O.S.), Boston Medical Center, Boston University School of Medicine, 820 Harrison Ave, 3rd Floor, Boston, MA 02118; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Mass (Y.M.C.); Department of Radiology, Veterans Administration Boston Healthcare System, Boston, Mass (M.N.C.); and Department of Radiology, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan (A.F.)
| | - Osamu Sakai
- From the Departments of Radiology (J.T., Y.M.C., M.N.C., K.H., A.F., O.S.), Ophthalmology (R.S.), Otolaryngology-Head and Neck Surgery (O.S.), and Radiation Oncology (O.S.), Boston Medical Center, Boston University School of Medicine, 820 Harrison Ave, 3rd Floor, Boston, MA 02118; Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Mass (Y.M.C.); Department of Radiology, Veterans Administration Boston Healthcare System, Boston, Mass (M.N.C.); and Department of Radiology, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan (A.F.)
| |
Collapse
|
5
|
Matet A, Amar N, Mohand-Said S, Sahel JA, Barale PO. Argus II retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-up. Clin Ophthalmol 2016; 10:1565-71. [PMID: 27574397 PMCID: PMC4993412 DOI: 10.2147/opth.s112403] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
Introduction The Argus II retinal prosthesis is composed of an epiretinal electrode array positioned over the macula and connected to an extrascleral electronics case via a silicone cable, running through a sclerotomy. During implantation, the manufacturer recommends to cover the sclerotomy site with a patch of processed human pericardium to prevent postoperative hypotony and conjunctival erosion by the underlying electronics case. Due to biomedical regulations prohibiting the use of this material in France, we developed an alternative technique combining a scleral flap protecting the sclerotomy and an autogenous graft of superior temporalis fascia overlying the electronics case. Methods The purpose of this study is to describe the 4-year outcomes of this modified procedure in three subjects who underwent Argus II Retinal Prosthesis System implantation. Clinical data consisting of intraocular pressure measurements and tolerance in terms of conjunctival erosion or inflammation were retrospectively assessed over a 4-year postoperative follow-up. Results None of the three patients implanted with the modified technique developed ocular hypotony over 4 years. A normal, transient conjunctival inflammation occurred during the first postoperative month but conjunctival erosion was not observed in any of the three patients over 4 years. Four years after implantation, the autogenous temporalis fascia graft remained well tolerated and the retinal prosthesis was functional in all three patients. Conclusion The combination of an autograft of superficial temporalis fascia and a scleral flap efficiently prevented leakage through the sclerotomy site, ocular hypotony, and conjunctival erosion by the extrascleral electronics case. This modified technique is suitable for the implantation of existing and forthcoming retinal prostheses. Superficial temporalis fascia may also be used as alternative to commercial tectonic tissues for scleral wound repair in clinical settings where they are not available.
Collapse
Affiliation(s)
- Alexandre Matet
- INSERM and DHOS, CHNO des Quinze-Vingts; Sorbonne Universités, UPMC Univ Paris 6, Institut de la Vision
| | - Nawel Amar
- INSERM and DHOS, CHNO des Quinze-Vingts; Sorbonne Universités, UPMC Univ Paris 6, Institut de la Vision
| | - Saddek Mohand-Said
- INSERM and DHOS, CHNO des Quinze-Vingts; Sorbonne Universités, UPMC Univ Paris 6, Institut de la Vision; INSERM; CNRS, Paris, France
| | - José-Alain Sahel
- INSERM and DHOS, CHNO des Quinze-Vingts; Sorbonne Universités, UPMC Univ Paris 6, Institut de la Vision; INSERM; CNRS, Paris, France; Institute of Ophthalmology, University College London, London, UK; Fondation Ophtalmologique Adolphe de Rothschild; Académie des Sciences, Institut de France, Paris, France
| | - Pierre-Olivier Barale
- INSERM and DHOS, CHNO des Quinze-Vingts; Sorbonne Universités, UPMC Univ Paris 6, Institut de la Vision
| |
Collapse
|